THISGENWellness
Secure checkout
Your orderProvider reviewDispensed & shipped

GHRH-Analog Protocol · Physician Supervised

Start your Tesamorelin protocol.

The compartment-specific option described in the article. A licensed provider reviews your information before anything is dispensed — and not everyone qualifies.

Tesamorelin 10mg lyophilized vial
Tesamorelin 10 mg (3 ml)Lyophilized · ships with home reconstitution kit

Choose your supply

Change or cancel any time before your order is dispensed.

Your detailsWhere your order ships. Encrypted, never shared.
Shipping
Payment
ItemQuantityPrice
1 Vial - 30-Day Supply
1
$165.00
3 Vials - 90-Day Supply
1
$429.00
6 Vials - 180-Day Supply
1
$779.00
Order summary
ItemQuantityAmount
1 Vial - 30-Day Supply1$ 165.00
Order Total
$0.00
* 100% Secure & Safe Payments *

Before you continue

Important information. Not all patients will qualify. Treatment is only initiated after a comprehensive medical evaluation by a licensed provider. Compounded preparations, when individually clinically justified, are dispensed by a US-licensed 503A compounding partner and are not FDA-approved.

Tesamorelin's FDA approval (as EGRIFTA) covers reduction of excess abdominal fat in HIV-infected patients with lipodystrophy specifically — use outside that indication is off-label, without registration-grade evidence in the general population. This page is not medical advice; consult a qualified healthcare provider. Individual results vary. You must be 21 or older to purchase.

ReferencesFalutz J, et al. (2007). N Engl J Med — Metabolic effects of a growth hormone-releasing factor in patients with HIV.
Falutz J, et al. (2010). Pooled analysis of two multicenter, double-blind, placebo-controlled phase 3 trials.
Meta-analysis of randomized controlled trials — Body composition, hepatic fat, metabolic and safety outcomes of tesamorelin.
U.S. FDA approval history for tesamorelin (EGRIFTA), 2010.
ThisGen LLC · 1918 Upton Village, San Antonio, TX 78260 · [email protected] · +1 956-821-0791